查看购物车
  • Traditional Chinese
  • English
  • Japanese
婴幼儿·儿童·母亲的益生菌补充品到2028年前的市场预测-COVID-19影响与形态和终端用户的全球分析
市场调查报告书
商品编码
1118356

婴幼儿·儿童·母亲的益生菌补充品到2028年前的市场预测-COVID-19影响与形态和终端用户的全球分析

Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Form (Capsules and Softgels, Gummies, Liquid, and Others) and End User (Infant and Toddler, Children, and Maternal Women)
出版日期: | 出版商: The Insight Partners | 英文 130 Pages | 订单完成后即时交付

价格

婴幼儿·儿童·母亲的益生菌补充品市场在2021年估算为6亿494万美元，到2028年达到10亿8170万美元。市场在2022年～2028年间，预测将以年复合成长率8.7％成长。

本报告提供全球婴幼儿·儿童·母亲的益生菌补充品市场相关调查，提供市场概要，以及各形态和终端用户，各地区的趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 简介

  • 调查范围
  • Insight Partners的调查报告书指导
  • 市场区隔

第2章 重要的要点

第3章 调查手法

  • 调查范围
  • 调查手法
    • 资料收集
    • 一次采访
    • 假设的形成
    • 宏观经济要素分析
    • 开发基数
    • 资料的三角测量
    • 国家级的资料
    • 限制和假设

第4章 婴幼儿·儿童·母亲的益生菌补充品市场形势

  • 市场概要
  • 波特的五力分析
    • 供给企业谈判力
    • 买方议价能力
    • 新加入厂商业者的威胁
    • 竞争企业间的竞争关係
    • 替代品的威胁
  • 专家的见解
  • 生态系统分析

第5章 婴幼儿·儿童·母亲的益生菌补充品市场- 主要市场动态

  • 推动市场要素
  • 阻碍市场要素
  • 市场机会
  • 今后趋势
  • 促进因素和阻碍因素的影响分析

第6章 婴幼儿·儿童·母亲的益生菌补充品-全球市场分析

  • 婴幼儿·儿童·母亲的益生菌补充品市场概要
  • 竞争的地位-主要市场企业

第7章 婴幼儿·儿童·母亲的益生菌补充品市场分析- 各形式

  • 婴幼儿·儿童·母亲的益生菌补充品市场，不同形态(2021年，2028年)
  • 胶囊和软凝胶
  • 软糖
  • 液体
  • 其他

第8章 婴幼儿·儿童·母亲的益生菌补充品市场分析- 各终端用户

  • 婴幼儿·儿童·母亲的益生菌补充品市场，各终端用户(2021年，2028年)
  • 婴幼儿·幼儿
  • 儿童
  • 母子家庭的女性

第9章 婴幼儿·儿童·母亲的益生菌补充品市场- 各地区分析

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 中国
    • 日本
    • 澳洲
    • 纽西兰
    • 其他亚太地区
  • 全球其他地区
    • 中南美
    • 中东和非洲

第10章 产业的形势

  • 产品的销售
  • 事业扩大

第11章 COVID-19疫情对婴幼儿·儿童·母亲的益生菌补充品市场带来的影响

  • COVID-19婴幼儿·儿童·母亲的益生菌补充品市场的影响
  • 北美
  • 欧洲 COVID-19疫情影响评估
  • 亚太地区
  • 中东·非洲
  • 中南美

第12章 企业简介

  • Bayer Corporation
  • MaryRuth Organics, LLC
  • Mommy's Bliss Inc.
  • Pharmavite LLC
  • Nestle S.A.
  • BioGaia AB
  • Evolve Biosystems
  • Lovebug Probiotics
  • Biomeology
  • Nordic Naturals

第13章 附录

  • The Insight Partners
  • 单词索引
Product Code: TIPRE00029530

The infant, child, and maternal probiotic supplements market is projected to reach US$ 1,081.70 million by 2028 from US$ 604.94 million in 2021. It is expected to grow at a CAGR of 8.7% from 2022 to 2028.

Probiotics are live micro-organisms that promote good digestive health and help to improve human gut health. They play a vital role in preventive healthcare as they prevent the occurrence of diseases by strengthening the immune system. Gut health has become one of the prime health concerns among consumers. Increasing awareness regarding the benefits of probiotics has surged their popularity in infant, child, and maternal women health supplements. These factors are significantly driving the demand for these supplements across the world. There is a rising prevalence of digestive disorders due to unhealthy consumption habits amongst children. This factor provides a strong potential to the infant, child, and maternal probiotic supplements market.

Based on end use, the infant, child, and maternal probiotic supplements market is segmented into infant and toddler, children, and maternal women. The children segment accounted for the largest market share in 2020. However, the maternal women segment is expected to register the highest CAGR during the forecast period.

Probiotic supplements are gaining popularity among pregnant women due to their role in reducing the risk of eczema in babies, lessening complications associated with childbirth, and improving the metabolic health of expectant mothers. Women experience dramatic changes in physiology and immune systems during pregnancy, including alterations in the gut microbiome population. These issues can be addressed using probiotic supplements. Probiotic supplements help pregnant women gain weight.

Based on region, the infant, child, and maternal probiotic supplements market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). In 2020, North America held the largest market share. Asia Pacific is estimated to register the fastest CAGR over the forecast period. The dominance of North America is attributed to the increasing awareness among consumers about the benefits of probiotic supplements for infants, children, and pregnant women. Parents in the region are more concerned about their children's development and growth.

Some common health conditions observed in the region include allergies, asthma, urinary tract infection, colic in infants, and autism. According to the Allergy & Asthma Foundation of Asthma, in 2018, approximately 5.2 thousand children in the US were diagnosed with seasonal allergic rhinitis. Increasing health issues among children have concerned parents, which in turn, has resulted in the rising uptake of probiotic supplements.

Moreover, governments of North American countries are taking initiatives to improve infant and children's health. For instance, Healthy Start is one initiative to improve childhood health care. This initiative is designed to reduce the infant mortality rate and improve prenatal health in the region. Hence, the prenatal and postnatal use of probiotic supplements is further surging the growth of the infant, child, and maternal probiotic supplements market across North America.

The key players operating in the infant, child, and maternal probiotic supplements market include Bayer Corporation; Nestle S.A.; Mommy's Bliss Inc.; LoveBug Probiotics; BioGaia AB; MaryRuth Organics, LLC; Pharmavite LLC; Evolve Biosystems; Biomeology; and Nordic Naturals. These companies are focusing on new product launches and geographical expansions to meet the growing consumer demand worldwide.

The overall infant, child, and maternal probiotic supplements market size has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. Also, multiple primary interviews have been conducted with industry participants to validate the data and gain more analytical insights into the topic. The participants of this process include industry experts such as VPs, business development managers, market intelligence managers, national sales managers, and external consultants, such as valuation experts, research analysts, and key opinion leaders, specializing in the Infant, Child, and Maternal Probiotic Supplements Market.

Reasons to Buy:

  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global infant, child, and maternal probiotic supplements market, thereby allowing players to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth the market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation, and industry verticals.

Table Of Contents

1. Introduction

  • 1.1 Study Scope
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation

2. Key Takeaways

3. Research Methodology

  • 3.1 Scope of the Study
  • 3.2 Research Methodology
    • 3.2.1 Data Collection:
    • 3.2.2 Primary Interviews:
    • 3.2.3 Hypothesis Formulation:
    • 3.2.4 Macro-economic Factor Analysis:
    • 3.2.5 Developing Base Number:
    • 3.2.6 Data Triangulation:
    • 3.2.7 Country Level Data:
    • 3.2.8 Limitations and Assumptions:

4. Infant, Child, and Maternal Probiotic Supplements Market Landscape

  • 4.1 Market Overview
  • 4.2 Porter's Five Forces Analysis
    • 4.2.1 Bargaining Power of Suppliers
    • 4.2.2 Bargaining Power of Buyers
    • 4.2.3 Threat of New Entrants
    • 4.2.4 Competitive Rivalry
    • 4.2.5 Threat of Substitutes
  • 4.3 Expert Opinion
  • 4.4 Ecosystem Analysis

5. Infant, Child, and Maternal Probiotic Supplements Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Demand for Probiotic Supplements in Paediatric Nutrition
    • 5.1.2 Growing Awareness Regarding Benefits of Probiotic Supplements among Pregnant Women
  • 5.2 Market Restraints
    • 5.2.1 Consumer Perceptions on Probiotic Supplements for Newborn
  • 5.3 Market Opportunities
    • 5.3.1 Surging Demand in Developing Regions
  • 5.4 Future Trends
    • 5.4.1 Increasing Research and Development in Infant and Maternal Probiotics Space
  • 5.5 Impact Analysis of Drivers and Restraints

6. Infant, Child, and Maternal Probiotic Supplements - Global Market Analysis

  • 6.1 Infant, Child, and Maternal Probiotic Supplements Market Overview
  • 6.2 Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)
  • 6.3 Competitive Positioning - Key Market Players

7. Infant, Child, And Maternal Probiotic Supplements Market Analysis - By Form

  • 7.1 Overview
  • 7.2 Infant, Child, And Maternal Probiotic Supplements Market, By Form (2021 and 2028)
  • 7.3 Capsules and Softgels
    • 7.3.1 Overview
    • 7.3.2 Capsules and Softgels: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
  • 7.4 Gummies
    • 7.4.1 Overview
    • 7.4.2 Gummies: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
  • 7.5 Liquid:
    • 7.5.1 Overview
    • 7.5.2 Liquid: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Infant, Child, And Maternal Probiotic Supplements Market- Revenue and Forecast to 2028 (US$ Thousand)

8. Infant, Child, And Maternal Probiotic Supplements Market Analysis - By End User

  • 8.1 Overview
  • 8.2 Infant, Child, And Maternal Probiotic Supplements Market, By End User (2021 and 2028)
  • 8.3 Infant and Toddler
    • 8.3.1 Overview
    • 8.3.2 Infant and Toddler: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
  • 8.4 Children
    • 8.4.1 Overview
    • 8.4.2 Children: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
  • 8.5 Maternal Women
    • 8.5.1 Overview
    • 8.5.2 Maternal Women: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)

9. Infant, Child, and Maternal Probiotic Supplements Market - Geographic Analysis

  • 9.1 Overview
  • 9.2 North America: Infant, Child, and Maternal Probiotic Supplements Market
    • 9.2.1 North America: Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)
    • 9.2.2 North America: Infant, Child, and Maternal Probiotic Supplements Market, By Form
    • 9.2.3 North America: Infant, Child, and Maternal Probiotic Supplements Market, by End User
    • 9.2.4 North America: Infant, Child, and Maternal Probiotic Supplements Market, by Key Country
      • 9.2.4.1 US: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 9.2.4.1.1 US: Infant, Child, and Maternal Probiotic Supplements Market, By Form
        • 9.2.4.1.2 US: Infant, Child, and Maternal Probiotic Supplements Market, by End User
      • 9.2.4.2 Canada: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 9.2.4.2.1 Canada: Infant, Child, and Maternal Probiotic Supplements Market, By Form
        • 9.2.4.2.2 Canada: Infant, Child, and Maternal Probiotic Supplements Market, by End User
      • 9.2.4.3 Mexico: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 9.2.4.3.1 Mexico: Infant, Child, and Maternal Probiotic Supplements Market, By Form
        • 9.2.4.3.2 Mexico: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  • 9.3 Europe: Infant, Child, and Maternal Probiotic Supplements Market
    • 9.3.1 Europe: Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)
    • 9.3.2 Europe: Infant, Child, and Maternal Probiotic Supplements Market, By Form
    • 9.3.3 Europe: Infant, Child, and Maternal Probiotic Supplements Market, by End User
    • 9.3.4 Europe: Infant, Child, and Maternal Probiotic Supplements Market, by Key Country
      • 9.3.4.1 Germany: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 9.3.4.1.1 Germany: Infant, Child, and Maternal Probiotic Supplements Market, By Form
        • 9.3.4.1.2 Germany: Infant, Child, and Maternal Probiotic Supplements Market, by End User
      • 9.3.4.2 UK: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 9.3.4.2.1 UK: Infant, Child, and Maternal Probiotic Supplements Market, By Form
        • 9.3.4.2.2 UK: Infant, Child, and Maternal Probiotic Supplements Market, by End User
      • 9.3.4.3 France: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 9.3.4.3.1 France: Infant, Child, and Maternal Probiotic Supplements Market, By Form
        • 9.3.4.3.2 France: Infant, Child, and Maternal Probiotic Supplements Market, by End User
      • 9.3.4.4 Italy: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 9.3.4.4.1 Italy: Infant, Child, and Maternal Probiotic Supplements Market, By Form
        • 9.3.4.4.2 Italy: Infant, Child, and Maternal Probiotic Supplements Market, by End User
      • 9.3.4.5 Russia: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 9.3.4.5.1 Russia: Infant, Child, and Maternal Probiotic Supplements Market, By Form
        • 9.3.4.5.2 Russia: Infant, Child, and Maternal Probiotic Supplements Market, by End User
      • 9.3.4.6 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
        • 9.3.4.6.1 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market, By Form
        • 9.3.4.6.2 Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  • 9.4 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market
    • 9.4.1 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
    • 9.4.2 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by Form
    • 9.4.3 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by End User
    • 9.4.4 Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by Key Country
      • 9.4.4.1 China: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
        • 9.4.4.1.1 China: Infant, Child, and Maternal Probiotic Supplements Market, by Form
        • 9.4.4.1.2 China: Infant, Child, and Maternal Probiotic Supplements Market, by End User
      • 9.4.4.2 Japan: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
        • 9.4.4.2.1 Japan: Infant, Child, and Maternal Probiotic Supplements Market, by Form
        • 9.4.4.2.2 Japan: Infant, Child, and Maternal Probiotic Supplements Market, by End User
      • 9.4.4.3 Australia: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
        • 9.4.4.3.1 Australia: Infant, Child, and Maternal Probiotic Supplements Market, by Form
        • 9.4.4.3.2 Australia: Infant, Child, and Maternal Probiotic Supplements Market, by End User
      • 9.4.4.4 New Zealand: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
        • 9.4.4.4.1 New Zealand: Infant, Child, and Maternal Probiotic Supplements Market, by Form
        • 9.4.4.4.2 New Zealand: Infant, Child, and Maternal Probiotic Supplements Market, by End User
      • 9.4.4.5 Rest of Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
        • 9.4.4.5.1 Rest of Asia-Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by Form
        • 9.4.4.5.2 Rest of Asia-Pacific: Infant, Child, and Maternal Probiotic Supplements Market, by End User
  • 9.5 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market
    • 9.5.1 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
    • 9.5.2 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market, by Form
    • 9.5.3 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market, by End User
    • 9.5.4 Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market, by Key Region
      • 9.5.4.1 South and Central America: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
        • 9.5.4.1.1 South and Central America: Infant, Child, and Maternal Probiotic Supplements Market, by Form
        • 9.5.4.1.2 South and Central America: Infant, Child, and Maternal Probiotic Supplements Market, by End User
      • 9.5.4.2 Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
        • 9.5.4.2.1 Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market, by Form
        • 9.5.4.2.2 Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market, by End User

10. Industry Landscape

  • 10.1 Overview
  • 10.2 Product launch
  • 10.3 Expansion

11. Impact of COVID-19 Pandemic on Infant, Child, and Maternal Probiotic Supplements Market

  • 11.1 Impact of COVID-19 on Infant, Child, and Maternal Probiotic Supplements Market
  • 11.2 North America: Impact Assessment of COVID-19 Pandemic
  • 11.3 Europe Impact Assessment of COVID-19 Pandemic
  • 11.4 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.5 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
  • 11.6 South & Central America: Impact Assessment of COVID-19 Pandemic

12. COMPANY PROFILES

  • 12.1 Bayer Corporation
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 MaryRuth Organics, LLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Mommy's Bliss Inc.
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Pharmavite LLC
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Nestle S.A.
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 BioGaia AB
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Evolve Biosystems
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Lovebug Probiotics
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Biomeology
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Nordic Naturals
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners
  • 13.2 Word Index

List Of Tables

  • Table 1. Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)
  • Table 2. Global Infant, Child, And Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 3. Global Infant, Child, And Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 4. North America Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 5. North America Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 6. US Infant, Child, and Maternal Probiotic Supplements Market, Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 7. US Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 8. Canada Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 9. Canada Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 10. Mexico Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 11. Mexico Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 12. Europe: Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 13. Europe: Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 14. Germany Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 15. Germany Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 16. UK Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 17. UK Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 18. France Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 19. France Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 20. Italy Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 21. Italy Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 22. Russia Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 23. Russia Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 24. Rest of Europe Infant, Child, and Maternal Probiotic Supplements Market, By Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 25. Rest of Europe Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 26. Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 27. Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 28. China Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 29. China Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 30. Japan: Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 31. Japan Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 32. Australia Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 33. Australia Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 34. New Zealand Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 35. New Zealand Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 36. Rest of Asia-Pacific Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 37. Rest of Asia-Pacific Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 38. Rest of the World Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 39. Rest of the World Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 40. South and Central America Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 41. South and Central America Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 42. Middle East and Africa Infant, Child, and Maternal Probiotic Supplements Market, by Form - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 43. Middle East and Africa Infant, Child, and Maternal Probiotic Supplements Market, by End User - Revenue and Forecast to 2028 (US$ Thousand)
  • Table 44. List of Abbreviation

List Of Figures

  • Figure 1. Infant, Child, and Maternal Probiotic Supplements Market Segmentation
  • Figure 2. Infant, Child, and Maternal Probiotic Supplements Market Segmentation - By Geography
  • Figure 3. Global Infant, Child, and Maternal Probiotic Supplements Market Overview
  • Figure 4. Infant, Child, and Maternal Probiotic Supplements Market: By Form
  • Figure 5. Infant, Child, and Maternal Probiotic Supplements Market: By Region
  • Figure 6. Global Infant, Child, and Maternal Probiotic Supplements Market, Key Market Players
  • Figure 7. Porter's Five Forces Analysis: Infant, Child, and Maternal Probiotic Supplements Market
  • Figure 8. Expert Opinion
  • Figure 9. Ecosystem: Infant, Child, and Maternal Probiotic Supplements Market
  • Figure 10. Infant Mortality Rate: The US, 2010-2020
  • Figure 11. Global Infant, Child, and Maternal Probiotic Supplements Market Impact Analysis of Drivers and Restraints
  • Figure 12. Geographic Overview of Infant, Child, and Maternal Probiotic Supplements Market
  • Figure 13. Global: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 14. Key Players: Infant, Child, and Maternal Probiotic Supplements Market
  • Figure 15. Infant, Child, And Maternal Probiotic Supplements Market Revenue Share, By Form (2021 and 2028)
  • Figure 16. Capsules and Softgels: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
  • Figure 17. Gummies: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
  • Figure 18. Liquid: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
  • Figure 19. Others: Infant, Child, And Maternal Probiotic Supplements Market- Revenue and Forecast To 2028 (US$ Thousand)
  • Figure 20. Infant, Child, And Maternal Probiotic Supplements Market Revenue Share, By End User (2021 and 2028)
  • Figure 21. Infant and Toddler: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
  • Figure 22. Children: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
  • Figure 23. Maternal Women: Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast To 2028 (US$ Thousand)
  • Figure 24. Global Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, By Region (2021 and 2028)
  • Figure 25. North America: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 26. North America: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, By Form (2021 and 2028)
  • Figure 27. North America: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by End User (2021 and 2028)
  • Figure 28. North America: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Key Country (2021 and 2028)
  • Figure 29. US: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 30. Canada: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 31. Mexico: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 32. Europe: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 33. Europe: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, By Form (2021 and 2028)
  • Figure 34. Europe: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by End User (2021 and 2028)
  • Figure 35. Europe: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Key Country (2021 and 2028)
  • Figure 36. Germany: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 37. UK: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 38. France: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 39. Italy: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 40. Russia: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 41. Rest of Europe: Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 42. Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 43. Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Form (2021 and 2028)
  • Figure 44. Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by End User (2021 and 2028)
  • Figure 45. Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Key Country (2021 and 2028)
  • Figure 46. China: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 47. Japan: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 48. Australia: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 49. New Zealand: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 50. Rest of Asia Pacific: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 51. Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market- Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 52. Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Form (2020 and 2028)
  • Figure 53. Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by End User (2021 and 2028)
  • Figure 54. Rest of the World: Infant, Child, and Maternal Probiotic Supplements Market Revenue Share, by Key Region (2021 and 2028)
  • Figure 55. South and Central America: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 56. Middle East and Africa: Infant, Child, and Maternal Probiotic Supplements Market-Revenue and Forecast to 2028 (US$ Thousand)
  • Figure 57. Impact of COVID-19 Pandemic on North America Infant, Child, and Maternal Probiotic Supplements Market
  • Figure 58. Impact of COVID-19 Pandemic on Europe Infant, Child, and Maternal Probiotic Supplements Market
  • Figure 59. Impact of COVID-19 Pandemic on Asia Pacific Infant, Child, and Maternal Probiotic Supplements Market
  • Figure 60. Impact of COVID-19 Pandemic on the Middle East & Africa Infant, Child, and Maternal Probiotic Supplements Market
  • Figure 61. Impact of COVID-19 Pandemic on South & Central America Infant, Child, and Maternal Probiotic Supplements Market